.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
McKesson
Queensland Health
Argus Health
Dow
Cantor Fitzgerald
Accenture
AstraZeneca
Boehringer Ingelheim

Generated: January 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 10-079039

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
AstellasASTAGRAF XLtacrolimusCAPSULE, EXTENDED RELEASE;ORAL204096-001Jul 19, 2013RXYesNo➤ Subscribe➤ SubscribeY
AstellasASTAGRAF XLtacrolimusCAPSULE, EXTENDED RELEASE;ORAL204096-002Jul 19, 2013RXYesNo➤ Subscribe➤ SubscribeY
AstellasASTAGRAF XLtacrolimusCAPSULE, EXTENDED RELEASE;ORAL204096-003Jul 19, 2013RXYesYes➤ Subscribe➤ SubscribeY
AstellasASTAGRAF XLtacrolimusCAPSULE, EXTENDED RELEASE;ORAL204096-001Jul 19, 2013RXYesNo➤ Subscribe➤ SubscribeY
AstellasASTAGRAF XLtacrolimusCAPSULE, EXTENDED RELEASE;ORAL204096-002Jul 19, 2013RXYesNo➤ Subscribe➤ SubscribeY
AstellasASTAGRAF XLtacrolimusCAPSULE, EXTENDED RELEASE;ORAL204096-003Jul 19, 2013RXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist